Chung Wendy — SEC insider filings
SEC reporting owner CIK 1922605. 13 insider filings on record with FilingPulse; latest filed 2026-10-28.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2022-08-03 to 2026-10-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Prime Medicine, Inc. (PRME) | Director | 6 | — | — | 13 |
| Rallybio Corp (RLYB) | Director | 7 | — | — | 9 |
Insider filings — Chung Wendy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-28 | 4 | Rallybio Corp (RLYB) | Option exercise (M): 2,062 @ $15.28 · Option exercise (M): 2,062 (derivative) @ $0 | EDGAR |
| 2026-09-18 | 4 | Rallybio Corp (RLYB) | Option exercise (M): 3,562 @ $2.38 · Option exercise (M): 3,562 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-08-05 | 4 | Prime Medicine, Inc. (PRME) | Disposition to issuer (D): 13,510 (derivative) · Grant/award (A): 13,510 (derivative) · Disposition to issuer (D): 9,006 (derivative) · Grant/award (A): 9,006 (derivative) · Disposition to issuer (D): 39,062 (derivative) · Grant/award (A): 39,062 (derivative) · +2 more | EDGAR |
| 2025-06-05 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 39,062 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 12,353 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 9,482 (derivative) @ $0 | EDGAR |
| 2022-10-21 | 4 | Prime Medicine, Inc. (PRME) | Grant/award (A): 9,006 (derivative) @ $0 | EDGAR |
| 2022-08-03 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 26,880 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1922605 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs